Byung Tae Choi Selected Research

O-(N-morpholinocarbonyl)-3-phenyllactic acid

5/2006

Effects of mycelial culture of Phellinus linteus on ethanol-induced gastric ulcer in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byung Tae Choi Research Topics

Disease

22	Neoplasms (Cancer) 07/2022 - 12/2002
17	Ischemic Stroke 07/2022 - 01/2013
13	Infarction (Infarctions) 01/2022 - 08/2011
13	Stroke (Strokes) 01/2022 - 08/2011
12	Brain Ischemia (Cerebral Ischemia) 07/2022 - 08/2011
11	Ischemia 10/2020 - 01/2014
11	Leukemia 08/2013 - 06/2005
10	Brain Injuries (Brain Injury) 01/2020 - 09/2014
8	Carcinoma (Carcinomatosis) 03/2013 - 12/2002
7	Cognitive Dysfunction 01/2022 - 05/2011
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 08/2011
7	Hypoxia (Hypoxemia) 10/2020 - 03/2011
4	Melanoma (Melanoma, Malignant) 01/2020 - 10/2010
3	Brain Diseases (Brain Disorder) 10/2020 - 01/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2007
3	Cerebral Palsy (Spastic Diplegia) 01/2018 - 05/2017
3	Neuroinflammatory Diseases 08/2016 - 01/2015
3	Hypercholesterolemia 09/2014 - 08/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2009 - 11/2007
2	Parkinson Disease (Parkinson's Disease) 05/2022 - 01/2020
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 03/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 06/2006
2	Amyloid Plaque 01/2020 - 06/2006
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 11/2015
2	Brain Edema (Cerebral Edema) 03/2016 - 05/2015
2	Edema (Dropsy) 01/2016 - 01/2014
2	Atherosclerosis 09/2014 - 08/2011
2	Necrosis 03/2011 - 05/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2006 - 05/2004
1	Neurobehavioral Manifestations 01/2020
1	Gliosis 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019

Drug/Important Bio-Agent (IBA)

10	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2022 - 01/2013
8	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2008
5	Cilostazol (Pletal)FDA LinkGeneric 02/2017 - 05/2011
5	CaspasesIBA 08/2013 - 06/2005
4	Therapeutic UsesIBA 05/2022 - 01/2020
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 08/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015 - 11/2008
3	Nerve Growth Factors (Neurotrophins)IBA 07/2022 - 01/2020
3	InflammasomesIBA 01/2022 - 11/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2013
3	Aripiprazole (Abilify)FDA Link 01/2018 - 01/2015
3	AntioxidantsIBA 08/2016 - 05/2006
3	Probucol (Lorelco)FDA Link 08/2016 - 08/2011
3	Neuroprotective AgentsIBA 07/2016 - 01/2011
3	LipopolysaccharidesIBA 01/2015 - 05/2004
3	Monophenol Monooxygenase (Tyrosinase)IBA 05/2012 - 10/2010
3	Melanins (Melanin)IBA 05/2012 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 10/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2006 - 06/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 01/2020
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2022 - 01/2020
2	linderalactoneIBA 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2014
2	Amyloid beta-PeptidesIBA 01/2020 - 06/2006
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2006
2	Phosphotransferases (Kinase)IBA 01/2019 - 12/2008
2	Oxygen (Dioxygen)IBA 01/2018 - 03/2013
2	Apolipoproteins E (ApoE)IBA 08/2016 - 08/2011
2	LipidsIBA 08/2016 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 07/2016 - 06/2015
2	Evans Blue (Blue, Evans)FDA Link 03/2016 - 05/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2015 - 09/2014
2	Peptide Hydrolases (Proteases)FDA Link 11/2015 - 06/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 11/2007
2	CytokinesIBA 01/2015 - 03/2011
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 10/2011 - 03/2008
2	naringeninIBA 02/2011 - 03/2009
2	Biological ProductsIBA 01/2010 - 08/2004
2	esculetinIBA 12/2008 - 03/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2008 - 05/2005
2	CurcuminIBA 09/2007 - 05/2006
2	ResveratrolIBA 06/2006 - 02/2004
2	beta-lapachoneIBA 01/2006 - 11/2003
2	quinone (benzoquinone)IBA 01/2006 - 11/2003
2	Methylnitronitrosoguanidine (MNNG)IBA 06/2005 - 10/2004
2	Alkylating AgentsIBA 06/2005 - 10/2004
2	NF-kappa B (NF-kB)IBA 05/2004 - 11/2003
1	AntigensIBA 07/2022
1	Free Radical ScavengersIBA 07/2022
1	EdaravoneIBA 07/2022
1	Neurotrophin 3IBA 07/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	Insulysin (Insulin-Degrading Enzyme)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	LuciferasesIBA 01/2020

Therapy/Procedure

16	Therapeutics 07/2022 - 08/2011
15	Electroacupuncture 07/2022 - 02/2012
4	Acupuncture Points (Acupuncture Point) 07/2022 - 01/2014
3	Transcranial Direct Current Stimulation 05/2022 - 01/2020
3	Low-Level Light Therapy (LLLT) 01/2022 - 01/2016
2	East Asian Traditional Medicine (Oriental Medicine) 06/2005 - 05/2004